Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 6.59
+0.13 (2.01%)
Sep 17, 2025, 4:46 PM CET
Genomtec Revenue
Genomtec had revenue of 5.00K PLN in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 6.00K, down -106.74% year-over-year. In the year 2024, Genomtec had annual revenue of 1,000.00.
Revenue (ttm)
6.00K
Revenue Growth
-106.74%
P/S Ratio
16,329.06
Revenue / Employee
230.77
Employees
26
Market Cap
97.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | - | - |
| Dec 31, 2023 | 1,000.00 | -39.00K | -97.50% |
| Dec 31, 2022 | 40.00K | -179.00K | -81.74% |
| Dec 31, 2021 | 219.00K | 199.00K | 995.00% |
| Dec 31, 2020 | 20.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.17B |
| NEUCA | 13.04B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 560.38M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Selvita | 359.79M |
| Centrum Medyczne ENEL-MED | 762.83M |